Proliferative activity of Hurthle cell thyroid tumours

Oncology

Volumn 57, Issue 1, 1999, Pages 17-22

  Cör, Andrej ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Ag NOR; Hurthle cell tumour; MIB 1; PCNA

Indexed keywords

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ONCOCYTOMA; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL; ADENOCARCINOMA; CELL DIVISION; CHEMISTRY; PATHOLOGY; THYROID TUMOR;

AUTOANTIGEN; CELL NUCLEUS ANTIGEN; CYCLINE; KI 67 ANTIGEN; NUCLEAR PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; ADENOMA, OXYPHILIC; ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PROLIFERATING CELL NUCLEAR ANTIGEN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032587421     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011995     Document Type: Article

References (32)

1. Tallini G, Carcangiu ML, Rosai J: Oncocytic neoplasms of the thyroid gland. Acta Pathol Jpn 1992;42:305-315.
2. Harry NM: Hürthle cell tumours of the thyroid gland. Melbourne Hosp Clin Rep 1941;12:18-21.
3. Thompson NW, Dunn EL, Batsahis JG, Nishiama RH: Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet 1974;139:555-560.
4. Gonzales-Campora R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H: Hürthle cell and mitochondrion-rich cell tumours: A clinicopathologic study. Cancer 1986;57:1154-1158.
5. Hedinger CE, Williams ED, Sobin LH: Histological typing of thyroid tumours, ed 2. Berlin, Springer, 1988.
6. Pich A, Margaria E, Chiusa L: Proliferative activity is a significant prognostic factor in male breast carcinoma. Am J Pathol 1994;145: 481-489.
7. Ploton D, Menager M, Jeanesson P, Himber G, Pigeon F, Adnet JJ: Improvement in the staining and in the visualisation of the argyrophylic proteins of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
8. Crocker J, Nar P: Nucleolar organizer regions in lymphomas. J Pathol 1987;151:111-118.
9. Underwood JCE, Giri DD: Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol 1988;155:95-96.
10. Bravo R, Mcdonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 1987;105: 1549-1554.
11. McCormick D, Chong H, Hobbs C, Catta C, Hall PA: Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB-1. Histopathology 1993;22:355-360.
12. Li Volsi V: Hürthle cell lesions; in Li Volsi V (ed): Surgical pathology of the thyroid gland. Philadelphia, Saunders, 1990, pp 131-288.
13. Grant CS, Barr D, Goelner JR, Hay ID: Benign Hürthle cell tumors of the thyroid: A diagnosis to be trusted? World J Surg 1988;12:488-495.
14. Bruni F, Batsahis JG, Luna MA, Remmler D: Hürthle cell tumours of the thyroid gland. J Clin Pathol 1987;88:528.
15. Bronner MP, Li Volsi V: Oxyphilic (Askanasiy/ Hürthle cell) tumours of the thyroid gland. Microscopic features predict biologic behaviour. Surg Pathol 1988;1:137-150.
16. Gundry SR, Rurney RE, Thompson NW, Lloyd R: Total thyroidectomy for Hürthle cell neoplasm of the thyroid. Arch Surg 1983;118: 529-532.
17. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J: Follicular Hürthle cell tumours of the thyroid gland. Cancer 1991;68:1944-1953.
18. Derenzini M, Ploton D: Interphase nucleolar organizer regions; in Crocker J (ed): Molecular biology in histopathology. Chichester, Wiley, 1994, pp 121-149.
19. Cor A, Pajer Z: Measurement characteristics of stereological and histochemical methods in the diagnosis of thyroid tumours. Oncology 1994;51:426-429.
20. Nairn ER, Crocker J, McGovern J: Limited value of Ag-NOR enumeration in assessment of thyroid neoplasms. J Clin Pathol 1989;41: 1136.
21. Ruschoff J, Prasser C, Cortez T, Höhne HM, Hohenberger W, Hofstädter F: Diagnostic value of Ag-NOR staining in follicular cell neoplasms of the thyroid. Am J Surg Pathol 1993;17:1281-1288.
22. Hall PA, Levison DA: Assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-192.
23. Shimizu T, Usuda N, Yamanada T, Sugenoya A, Iida F: Proliferative activity of human thyroid tumours evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer 1993;71:2807-2812.
24. Xu YJ: Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma (Chinese). Chung-Hua Ko Tsa Chih 1993;31:628-629.
25. Tateyama H, Yang YP, Eimoto T, Tada T, Inagahi H, Nakamura T, Iwase H, Kobayashi S: Proliferative cell nuclear antigen expression in follicular tumours of the thyroid with special reference to oxyphylic cell lesions. Virchows Arch 1994;424:533-537.
26. Bacus S, Flowers JL, Press MF, Bacus JW, McCarty KS: The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 1988;90:233-239.
27. Rigaud C, Bogomoletz WV: Apparent lack of usefulness of monoclonal antibody Ki-67 in thyroid tumour pathology. Pathol Res Pract 1991;187:198-200.
28. Zidar N, Gale N, Cör A, Kambič V: Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol 1996;110: 440-445.
29. Sabattini E, Gerdes J, Gherlinzoni F, Poggi S, Zucchini L, Mellili G, Grigioni F, del Vecchio MT, Leoncini L, Falini B, Pileri SA: Comparison between the monoclonal antibodies Ki-67 and PCNA in 125 malignant lymphomas. J Pathol 1993;169:397-403.
30. McCormick D, Hall PA: The complexities of proliferating cell nuclear antigen. Histopathology 1992;21:391-394.
31. Linden MD, Chan K, Kubus J, Brown RD, Zarbo RJ: Ki-67 and proliferating cell nuclear antigen tumour proliferative indices in DNA diploid colorectal adenocarcinomas. Am J Clin Pathol 1993;100:206-212.
32. Brugal G: Interpretation of proliferation markers. 8th Int Symp Diagnostic Quantitative Pathology, Amsterdam 1994, p 24.